Pediatricians can now give oseltamivir (Tamiflu) treatment to children as young as 2 weeks who have had influenza symptoms for no more than 2 days. This approval was based on studies in safety and pharmacokinetics conducted by Roche, which makes oseltamivir, and the NIH.



